Extracellular NAD+ induces a rise in [Ca2+]i in activated human monocytes via engagement of P2Y1 and P2Y11 receptors

Cell Calcium

Volumn 46, Issue 4, 2009, Pages 263-272

  Klein, Carina ^a   Grahnert, Anja ^a   Abdelrahman, Aliaa ^b   Müller, Christa E ^b   Hauschildt, Sunna ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Calcium; LPS; Monocytes; NAD+; P2 receptors

Indexed keywords

CALCIUM ION; INOSITOL TRISPHOSPHATE; LIPOPOLYSACCHARIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PURINERGIC P2 RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y11 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ACTIVATION; CELL TYPE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 70349820064     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2009.08.004     Document Type: Article

References (69)

1. Berger F., Ramirez-Hernandez M.H., and Ziegler M. The new life of a centenarian: signalling functions of NAD(P). Trends Biochem. Sci. 29 (2004) 111-118
2. + and NADH in cellular functions and cell death. Front. Biosci. 11 (2006) 3129-3148
3. Ziegler M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur. J. Biochem. 267 (2000) 1550-1564
4. Guse A.H. Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR). FEBS J. 272 (2005) 4590-4597
5. 2+ from acidic stores. Biochem. Soc. Trans. 34 (2006) 922-926
6. Seman M., Adriouch S., Scheuplein F., et al. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19 (2003) 571-582
7. Gasser A., Glassmeier G., Fliegert R., et al. Activation of T cell calcium influx by the second messenger ADP-ribose. J. Biol. Chem. 281 (2006) 2489-2496
8. Kuhn F.J., Heiner I., and Luckhoff A. TRPM2: a calcium influx pathway regulated by oxidative stress and the novel second messenger ADP-ribose. Pflugers Arch. 451 (2005) 212-219
9. Grubisha O., Rafty L.A., Takanishi C.L., et al. Metabolite of SIR2 reaction modulates TRPM2 ion channel. J. Biol. Chem. 281 (2006) 14057-14065
10. + regulates intracellular free calcium concentration in human monocytes. Biochem. J. 382 (2004) 849-856
11. Kim U.H., Kim M.K., Kim J.S., Han M.K., Park B.H., and Kim H.R. Purification and characterization of NAD glycohydrolase from rabbit erythrocytes. Arch. Biochem. Biophys. 305 (1993) 147-152
12. Davies C.A., Perrett D., Zhang Z., Nielsen B.R., Blake D.R., and Winyard P.G. Simultaneous analysis of nitrite, nitrate and the nicotinamide nucleotides by capillary electrophoresis: application to biochemical studies and human extracellular fluids. Electrophoresis 20 (1999) 2111-2117
13. Krebs C., Koestner W., Nissen M., et al. Flow cytometric and immunoblot assays for cell surface ADP-ribosylation using a monoclonal antibody specific for ethenoadenosine. Anal. Biochem. 314 (2003) 108-115
14. Jacobson E.L., and Jacobson M.K. Tissue NAD as a biochemical measure of niacin status in humans. Methods Enzymol. 280 (1997) 221-230
15. + released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo. J. Immunol. 179 (2007) 186-194
16. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 299-309
17. Fredholm B.B., Abbracchio M.P., Burnstock G., et al. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol. Sci. 18 (1997) 79-82
18. Burnstock G. Introduction: P2 receptors. Curr. Top. Med. Chem. 4 (2004) 793-803
19. + is an agonist of the human P2Y11 purinergic receptor in human granulocytes. J. Biol. Chem. 281 (2006) 31419-31429
20. Grahnert A., Klein C., and Hauschildt S. Involvement of P2X receptors in the NAD(+)-induced rise in [Ca (2+)] (i) in human monocytes. Purinergic Signal 5 (2009) 309-319
21. Guerra A.N., Fisette P.L., Pfeiffer Z.A., et al. Purinergic receptor regulation of LPS-induced signaling and pathophysiology. J. Endotoxin Res. 9 (2003) 256-263
22. + glycohydrolase by arabino analogues of beta-NAD. J. Biol. Chem. 267 (1992) 9606-9611
23. Grage-Griebenow E., Lorenzen D., Fetting R., Flad H.D., and Ernst M. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur. J. Immunol. 23 (1993) 3126-3135
24. Hillmann P., Ko G.-Y., Spinrath A., et al. Key determinants of nucleotide-activated G protein-coupled receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology of the human P2Y2 receptor. J. Med. Chem. 52 (2009) 2762-2775
25. Brunschweiger A., Iqbal J., Umbach F., et al. Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5′-carboxamide. J. Med. Chem. 51 (2008) 4518-4528
26. Kaulich M., Streicher F., Mayer R., Müller I., and Müller C.E. Flavonoids-novel lead compounds for the development of P2Y2 receptor antagonists. Drug Dev. Res. 59 (2003) 72-81
27. Thiele A., Wasner M., Muller C., Engeland K., and Hauschildt S. Regulation and possible function of beta-catenin in human monocytes. J. Immunol. 167 (2001) 6786-6793
28. Iqbal J., Levesque S.A., Sevigny J., and Muller C.E. A highly sensitive CE-UV method with dynamic coating of silica-fused capillaries for monitoring of nucleotide pyrophosphatase/phosphodiesterase reactions. Electrophoresis 29 (2008) 3685-3693
29. Iqbal J., Vollmayer P., Braun N., Zimmermann H., and Muller C.E. A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction. Purinergic Signal 1 (2005) 349-358
30. Pfister M., Ogilvie A., da Silva C.P., Grahnert A., Guse A.H., and Hauschildt S. NAD degradation and regulation of CD38 expression by human monocytes/macrophages. Eur. J. Biochem. 268 (2001) 5601-5608
31. Takemura H., Hughes A.R., Thastrup O., and Putney Jr. J.W. Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J. Biol. Chem. 264 (1989) 12266-12271
32. 2+ release. J. Biochem. 122 (1997) 498-505
33. Bleasdale J.E., Thakur N.R., Gremban R.S., et al. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther. 255 (1990) 756-768
34. Oh-hora M., and Rao A. Calcium signaling in lymphocytes. Curr. Opin. Immunol. 20 (2008) 250-258
35. Penna A., Demuro A., Yeromin A.V., et al. The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature 456 (2008) 116-120
36. Parekh A.B., and Penner R. Store depletion and calcium influx. Physiol. Rev. 77 (1997) 901-930
37. Jacobson K.A., Jarvis M.F., and Williams M. Purine and pyrimidine (P2) receptors as drug targets. J. Med. Chem. 45 (2002) 4057-4093
38. Lambrecht G., Friebe T., Grimm U., et al. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur. J. Pharmacol. 217 (1992) 217-219
39. Dunn P.M., and Blakeley A.G. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br. J. Pharmacol. 93 (1988) 243-245
40. Burnstock G. Purine and pyrimidine receptors. Cell Mol. Life Sci. 64 (2007) 1471-1483
41. von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 110 (2006) 415-432
42. Parr C.E., Sullivan D.M., Paradiso A.M., et al. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 13067
43. von Kügelgen I., and Wetter A. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 310-323
44. Jacobson K.A., and Gao Z.G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5 (2006) 247-264
45. Di Virgilio F. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16 (1995) 524-528
46. Di Virgilio F., Chiozzi P., Falzoni S., et al. Cytolytic P2X purinoceptors. Cell Death Differ. 5 (1998) 191-199
47. Dubyak G.R., and el Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265 (1993) C577-C606
48. Fredholm B.B. Purines and neutrophil leukocytes. Gen. Pharmacol. 28 (1997) 345-350
49. Marteau F., Communi D., Boeynaems J.M., and Suarez G.N. Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells. J. Leukoc. Biol. 76 (2004) 796-803
50. Tonetti M., Sturla L., Giovine M., Benatti U., and De Flora A. Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNF-alpha in lipopolysaccharide-treated RAW 264.7 murine macrophages. Biochem. Biophys. Res. Commun. 214 (1995) 125-130
51. Ferrari D., Chiozzi P., Falzoni S., Hanau S., and Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185 (1997) 579-582
52. Di Virgilio F., Chiozzi P., Ferrari D., et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97 (2001) 587-600
53. Ballerini P., Rathbone M.P., Di Iorio P., et al. Rat astroglial P2Z (P2X7) receptors regulate intracellular calcium and purine release. Neuroreport 7 (1996) 2533-2537
54. Baricordi O.R., Ferrari D., Melchiorri L., et al. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87 (1996) 682-690
55. el Moatassim C., Dornand J., and Mani J.C. Extracellular ATP and cell signalling. Biochim. Biophys. Acta 1134 (1992) 31-45
56. Hide I., Tanaka M., Inoue A., et al. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J. Neurochem. 75 (2000) 965-972
57. Humphreys B.D., and Dubyak G.R. Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J. Immunol. 157 (1996) 5627-5637
58. Ross P.E., Ehring G.R., and Cahalan M.D. Dynamics of ATP-induced calcium signaling in single mouse thymocytes. J. Cell Biol. 138 (1997) 987-998
59. Wiley J.S., Chen J.R., Snook M.B., and Jamieson G.P. The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP. Br. J. Pharmacol. 112 (1994) 946-950
60. Beigi R.D., Kertesy S.B., Aquilina G., and Dubyak G.R. Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br. J. Pharmacol. 140 (2003) 507-519
61. Communi D., Govaerts C., Parmentier M., and Boeynaems J.M. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J. Biol. Chem. 272 (1997) 31969-31973
62. Torres B., Zambon A.C., and Insel P.A. P2Y11 receptors activate adenylyl cyclase and contribute to nucleotide-promoted cAMP formation in MDCK-D(1) cells. A mechanism for nucleotide-mediated autocrine-paracrine regulation. J. Biol. Chem. 277 (2002) 7761-7765
63. Qi A.D., Kennedy C., Harden T.K., and Nicholas R.A. Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase. Br. J. Pharmacol. 132 (2001) 318-326
64. Ullmann H., Meis S., Hongwiset D., et al. Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency. J. Med. Chem. 48 (2005) 7040-7048
65. Hague C., Uberti M.A., Chen Z., Hall R.A., and Minneman K.P. Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. J. Biol. Chem. 279 (2004) 15541-15549
66. Margeta-Mitrovic M., Jan Y.N., and Jan L.Y. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27 (2000) 97-106
67. Charles A.C., Mostovskaya N., Asas K., Evans C.J., Dankovich M.L., and Hales T.G. Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory. Mol. Pharmacol. 63 (2003) 89-95
68. Milligan G. G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discov. Today 11 (2006) 541-549
69. Ecke D., Hanck T., Tulapurkar M.E., et al. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. Biochem. J. 409 (2008) 107-116